acceleratory factor from growth hormone

ret proto-oncogene ; Homo sapiens







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 23660265 [Clinical manifestations, therapeutic response to tyrosinase inhibitor and RET gene activating mutation in a patient with multiple endocrine neoplasia 2B]. 2013 Feb 5 1
2 16829704 De novo multiple endocrine neoplasia type 2B with noncardiogenic pulmonary edema as the presenting symptom. 2006 Aug 1
3 12757658 [A case report and pedigree study of a single point mutation in RET proto-oncogene and type 2B multiple endocrine neoplasia]. 2003 Jan 2
4 11900218 Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. 2002 Jan 15 1
5 9706252 [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers]. 1998 1
6 7595170 Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. 1995 Oct 2
7 7627271 Tumor-specific mutations in the tyrosine kinase domain of the RET proto-oncogene in pheochromocytomas of sporadic type. 1995 Apr 2